Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes
Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2
Edelmiro Menéndez Torrea,
, Francisco Javier Lafita Tejedora, Sara Artola Menéndeza, Jesús Millán Núñez-Cortésb, Ángeles Alonso Garcíac, Manuel Puig Domingod, José Ramón García Solanse, Fernando Álvarez Guisasolaf, Javier García Alegríag, Javier Mediavilla Bravoh, Carlos Miranda Fernández-Santosi, Ramón Romero Gonzálezj
Corresponding author
a On behalf of the Working Group for Consensus and Clinical Guidelines of the Sociedad Española de Diabetes, Spain
b Sociedad Española de Arteriosclerosis (SEA), Spain
c Sociedad Española de Cardiología (SEC), Spain
d Sociedad Española de Endocrinología y Nutrición (SEEN), Spain
e Sociedad Española de Farmacia Comunitaria (SEFAC), Spain
f Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC), Spain
g Sociedad Española de Medicina Interna (SEMI), Spain
h Sociedad Española de Médicos de Atención Primaria (SEMERGEN), Spain
i Sociedad Española de Médicos Generales y de Familia (SEMG), Spain
j Sociedad Española de Nefrología (SEN), Spain
Ver másRead
2949
Timeswas read the article
1061
Total PDF
1888
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 42 | 8 | 50 |
| 2025 11 | 199 | 29 | 228 |
| 2025 10 | 85 | 12 | 97 |
| 2025 9 | 69 | 11 | 80 |
| 2025 8 | 119 | 10 | 129 |
| 2025 7 | 164 | 10 | 174 |
| 2025 6 | 66 | 1 | 67 |
| 2025 5 | 44 | 7 | 51 |
| 2025 4 | 30 | 3 | 33 |
| 2025 3 | 34 | 5 | 39 |
| 2025 2 | 31 | 5 | 36 |
| 2025 1 | 42 | 14 | 56 |
| 2024 12 | 20 | 4 | 24 |
| 2024 11 | 29 | 5 | 34 |
| 2024 10 | 12 | 1 | 13 |
| 2024 9 | 19 | 3 | 22 |
| 2024 8 | 24 | 8 | 32 |
| 2024 7 | 15 | 6 | 21 |
| 2024 6 | 8 | 5 | 13 |
| 2024 5 | 7 | 4 | 11 |
| 2024 4 | 11 | 6 | 17 |
| 2024 3 | 12 | 6 | 18 |
| 2024 2 | 12 | 7 | 19 |
| 2024 1 | 9 | 3 | 12 |
| 2023 12 | 9 | 16 | 25 |
| 2023 11 | 10 | 4 | 14 |
| 2023 10 | 16 | 6 | 22 |
| 2023 9 | 6 | 4 | 10 |
| 2023 8 | 6 | 6 | 12 |
| 2023 7 | 7 | 12 | 19 |
| 2023 6 | 10 | 4 | 14 |
| 2023 5 | 6 | 4 | 10 |
| 2023 4 | 3 | 2 | 5 |
| 2023 3 | 5 | 5 | 10 |
| 2023 2 | 3 | 7 | 10 |
| 2023 1 | 3 | 8 | 11 |
| 2022 12 | 7 | 5 | 12 |
| 2022 11 | 14 | 12 | 26 |
| 2022 10 | 8 | 13 | 21 |
| 2022 9 | 5 | 38 | 43 |
| 2022 8 | 11 | 10 | 21 |
| 2022 7 | 5 | 8 | 13 |
| 2022 6 | 11 | 12 | 23 |
| 2022 5 | 7 | 11 | 18 |
| 2022 4 | 8 | 7 | 15 |
| 2022 3 | 9 | 7 | 16 |
| 2022 2 | 9 | 5 | 14 |
| 2022 1 | 13 | 9 | 22 |
| 2021 12 | 11 | 12 | 23 |
| 2021 11 | 9 | 8 | 17 |
| 2021 10 | 6 | 10 | 16 |
| 2021 9 | 5 | 11 | 16 |
| 2021 8 | 5 | 9 | 14 |
| 2021 7 | 4 | 11 | 15 |
| 2021 6 | 6 | 22 | 28 |
| 2021 5 | 11 | 11 | 22 |
| 2021 4 | 22 | 20 | 42 |
| 2021 3 | 6 | 10 | 16 |
| 2021 2 | 14 | 9 | 23 |
| 2021 1 | 7 | 12 | 19 |
| 2020 12 | 10 | 9 | 19 |
| 2020 11 | 5 | 10 | 15 |
| 2020 10 | 4 | 8 | 12 |
| 2020 9 | 9 | 13 | 22 |
| 2020 8 | 9 | 6 | 15 |
| 2020 7 | 8 | 9 | 17 |
| 2020 6 | 5 | 4 | 9 |
| 2020 5 | 7 | 9 | 16 |
| 2020 4 | 5 | 2 | 7 |
| 2020 3 | 5 | 8 | 13 |
| 2020 2 | 4 | 6 | 10 |
| 2020 1 | 5 | 9 | 14 |
| 2019 12 | 21 | 28 | 49 |
| 2019 11 | 9 | 16 | 25 |
| 2019 10 | 7 | 6 | 13 |
| 2019 9 | 4 | 10 | 14 |
| 2019 8 | 0 | 16 | 16 |
| 2019 7 | 5 | 18 | 23 |
| 2019 6 | 20 | 24 | 44 |
| 2019 5 | 62 | 54 | 116 |
| 2019 4 | 21 | 63 | 84 |
| 2019 3 | 1 | 6 | 7 |
| 2019 2 | 2 | 14 | 16 |
| 2019 1 | 1 | 3 | 4 |
| 2018 12 | 6 | 13 | 19 |
| 2018 11 | 5 | 9 | 14 |
| 2018 10 | 7 | 23 | 30 |
| 2018 9 | 6 | 3 | 9 |
| 2018 8 | 2 | 9 | 11 |
| 2018 7 | 7 | 11 | 18 |
| 2018 6 | 3 | 7 | 10 |
| 2018 5 | 9 | 11 | 20 |
| 2018 4 | 1 | 6 | 7 |
| 2018 3 | 4 | 1 | 5 |
| 2018 2 | 1 | 5 | 6 |
| 2018 1 | 4 | 5 | 9 |
| 2017 12 | 3 | 5 | 8 |
| 2017 11 | 5 | 5 | 10 |
| 2017 10 | 7 | 4 | 11 |
| 2017 9 | 7 | 6 | 13 |
| 2017 8 | 7 | 4 | 11 |
| 2017 7 | 6 | 2 | 8 |
| 2017 6 | 15 | 24 | 39 |
| 2017 5 | 20 | 1 | 21 |
| 2017 4 | 17 | 7 | 24 |
| 2017 3 | 16 | 10 | 26 |
| 2017 2 | 44 | 1 | 45 |
| 2017 1 | 7 | 1 | 8 |
| 2016 12 | 7 | 1 | 8 |
| 2016 11 | 10 | 0 | 10 |
| 2016 10 | 12 | 3 | 15 |
| 2016 9 | 10 | 0 | 10 |
| 2016 8 | 9 | 0 | 9 |
| 2016 7 | 2 | 0 | 2 |
Show all
